|
AU2009297626A1
|
|
Aptamer for NGF and use thereof
|
|
JPH09301857A
|
|
Acetylcholine-based neural transmission improver
|
|
JPH09110845A
|
|
New 2-(n-cyanoimino)thiazolidin-4-one derivative
|
|
JPH09100298A
|
|
Trypsin inhibitor derivative having kallikrein inhibiting action
|
|
JPH0987166A
|
|
Medicine composition
|
|
JPH0841040A
|
|
New 2-(n-cyanoimino)thiazolidin-4-one derivative
|
|
JPH07118155A
|
|
Glucose ester derivative-containing agent for improvement of cerebral metabolism
|
|
JPH06247858A
|
|
Antiosteodystrophic agent in chronic renal failure
|
|
JPH06249852A
|
|
D-amino acid oxidizing enzyme polychlornal antibody and measurement of d-amino acid oxidizing enzyme using the antibody
|
|
JPH04208287A
|
|
7h-pyrido(3,2,1-ij) (2,1)benzoxazien derivative
|
|
JPH04208288A
|
|
7h-pyrido(3,2,1-ij) (2,1)benzoxazine derivative
|
|
JPH04210656A
|
|
Novel phenethyl alcohol derivative
|
|
JPH023609A
|
|
Long-acting drug preparation containing nicardipine hydrochloride as active component
|
|
JPH01287066A
|
|
Novel anthranilic acid derivative
|
|
JPH01258621A
|
|
Dilazep tablet with regulated absorption
|
|
JPH01254702A
|
|
Substance having antiallergic action and production thereof
|
|
JPH01165584A
|
|
Novel 1,8-naphtylidine derivative
|
|
JPS63313731A
|
|
Piroxicam external liquid preparation
|
|
JPS63297400A
|
|
Substance having antiallergic action and its production
|
|
JPS63269981A
|
|
Stabilization of elastase
|
